Efficacy and Safety Study in the Treatment of Chronic Diabetic Foot Ulcers
NCT00387101 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 288
Last updated 2008-05-02
Summary
The purpose of this study is to determine the safety and efficacy of Dermal-LSR plus Standard of Care (SOC) for the treatment of diabetic foot ulcers (DFU)in comparison to the treatment to SOC alone.
Conditions
- Diabetic Foot Ulcer
Interventions
- DEVICE
-
Dermal - Living Skin Replacement (Dermal - LSR)
Sponsors & Collaborators
-
ApoPharma
lead INDUSTRY
Principal Investigators
-
Jason R Hanft, DPM, FAC FAS · Doctors Research Network, 7000 SW 62nd Avenue, Suite 310, South Miami, FL 33143
-
Hau Pham, DPM · Foot Care Vascular and Endovascular Specialists of Boston Medical Center, 732 Harrison Ave., 2nd Floor, Boston, MA 02118
-
Rodney Stuck, DPM · Hines VA Hospital, 5th and Roosevelt Rd., Building 200, 5th Floor, Room 501, Hines, IL 60141
-
Vickie Driver, DPM · National Center for Lower Limb Preservation, 8816 Dempster Street, Niles, Il 60714
-
Zevi Isseroff, DPM · North Shore Diabetic and Endocrine Associates, 3003 New Hyde Park Road Suite 201, New Hyde Park, NY, 11042
-
Lowell Weil, Jr., DPM, MBA, FAC FAS · Weil Foot and Ankle Institute, 1455 Golf Rd., Suite 110, Golf-River Professional Building, Des Plaines, IL 60016
-
Michal Drews · SPSK nr 2 im. H. Święcickiego AM Oddział Kliniczny Chirurgii Ogólnej Gastroenterologicznej i Endokrynologicznej ul. Przybyszewskiego 49
-
Henryk Komon · Centrum Medyczno-Diagnostyczne Sp. z o.o. ul. Piłsudskiego 49 08-110 Siedlce Poland
-
Krystyna Pilarska · SPWSZ w Szczecinie Klinika Endokrynologii, NadciśnieniaTętniczego i Chorób Przemiany Materii PAM ul. Arkońska 4 71-455 Szczecin
-
Malgorzata Wilczynska · NZOZ Centrum Opieki Diabetologiczno-Endokrynologicznej ul. Karola Miarki 6 50-306 Wrocław Poland
-
Joseph Cavorsi, M.D. · Center for Advanced Wound Care 640 Walnut St., Suite 302 Reading, PA 19601
-
Roslyn R Isseroff, M.D. · Veterans Affairs Northern Health Care System
-
Georgeanne Botek, DPM · The Learner Research Centre, Department of Orthopaedic Surgery. The Cleveland Clinic Foundation, 9500 Euclid Ave. A40, Cleveland, OH 44195,
-
Adam Landsman, DPM, PhD · Joslin-Beth Israel Deaconess Foot Center, Division of Podiatry, 185 Pilgrim Road, Boston, MA 02215
-
Jodi Walters, DPM · Southern Arizona Veterans Administration Health Care System, 3601 S. 6th Avenue (2-112), Tucson, AZ 85723
-
Martin Taubman, DPM · San Diego Research Center 4452 Park Boulevard Suite 210, San Diego, CA 92116
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 84 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-02-28
- Primary Completion
- 2007-09-30
- Completion
- 2008-04-30
Countries
- United States
Study Locations
More Related Trials
-
PriMatrix for the Management of Diabetic Foot Ulcers
NCT03010319 ·Status: COMPLETED ·Phase: NA
-
Diabetic Foot Ulcer Recurrence: Pilot Study
NCT03479242 ·Status: TERMINATED
-
Resorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers
NCT03398538 ·Status: COMPLETED ·Phase: NA
-
Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers
NCT01830348 ·Status: TERMINATED ·Phase: PHASE3
-
Treatment of Diabetic Foot Ulcers With AUP1602-C
NCT04281992 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot Ulcers
NCT06852976 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers
NCT00330265 ·Status: UNKNOWN ·Phase: PHASE2
-
Adipose Derived Regenerative Cells In the Treatment of Diabetic Foot Ulcers
NCT05095389 ·Status: UNKNOWN ·Phase: PHASE3
-
dHACM Mesh In the Treatment of Diabetic Foot Ulcers
NCT02589210 ·Status: COMPLETED ·Phase: NA
-
Diabetic Foot Ulcers-Comparing Transforming Powder to Standard of Care
NCT05046158 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Effect of Topical Recombinant Human Vascular Endothelial Growth Factor for Induction of Healing of Diabetic Foot Ulcers
NCT00351767 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care
NCT06564831 ·Status: RECRUITING ·Phase: NA
-
Dynamic Plantar Microvascular Skin Response to Compressive Loads in At-risk Diabetic and Healthy Control: a Pilot Study
NCT01580917 ·Status: COMPLETED
-
Bioactive Split Thickness Skin Allograft Versus Standard of Care in the Treatment of Diabetic Foot Ulcers
NCT04040426 ·Status: COMPLETED ·Phase: NA
-
Platelet Rich Plasma VS Platelet Fibrin Plasma in Treatment of Diabetes Related Wound:a Randomized Controlled Trial
NCT05979584 ·Status: COMPLETED ·Phase: NA
-
Cellular Reprogramming-Enhanced Skin Grafting for Diabetic Foot Ulcers
NCT02070835 ·Status: COMPLETED ·Phase: NA
-
Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
NCT07086443 ·Status: RECRUITING ·Phase: PHASE4
-
Assessment of the Efficacy and Tolerance of Sub-cutaneous Re-injection of Autologous Adipose-derived REGEnerative Cells in the Local Treatment of Neuropathic Diabetic Foot ulcERs
NCT02866565 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Allogenic Dermis Versus Standard Care in the Management of Diabetic Foot Ulcers
NCT02331147 ·Status: COMPLETED ·Phase: NA
-
LeucoPatch™ Study A Multicenter Study on the Effect of LeucoPatch™ in Diabetic Foot Ulcers
NCT01454401 ·Status: COMPLETED ·Phase: NA
-
A Feasibility Study of the ReGenerCell™ Autologous Cell Harvesting Device for Diabetic Foot Ulcers
NCT02799121 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Human Placental Graft in Diabetic Foot Ulcers
NCT03708029 ·Status: TERMINATED ·Phase: NA
-
Developing a Diabetic Foot Ulcer Protocol
NCT01068171 ·Status: WITHDRAWN ·Phase: NA
-
A Dose Finding Study of Topically Applied I-020201 as an Adjunct to Good Standard-of-care in Patients With Chronic Diabetic Foot Ulcers
NCT00915486 ·Status: COMPLETED ·Phase: PHASE2
-
BB-101 for the Treatment of Diabetic Lower Leg and Foot Ulcers
NCT06383013 ·Status: RECRUITING ·Phase: PHASE2